Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Zafgen Inc (ZFGN)

Zafgen Inc (ZFGN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.9900 -0.1700 (-14.66%) 05/28/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.9900 unch (unch) -
Quote Overview for Thu, May 28th, 2020
Day Low
0.9500
Day High
1.2400
Open 1.0200
Previous Close 1.1600 1.1600
Volume 4,323,100 4,323,100
Avg Vol 992,950 992,950
Stochastic %K 62.75% 62.75%
Weighted Alpha -47.56 -47.56
5-Day Change +0.1025 (+11.55%) +0.1025 (+11.55%)
52-Week Range 0.6191 - 2.7600 0.6191 - 2.7600
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 37,095
  • Shares Outstanding, K 37,470
  • Annual Sales, $ 0 K
  • Annual Income, $ -45,410 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.27
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.73
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.81
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/14/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.32
  • Growth Rate Est. (year over year) +312,287.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7400 +33.78%
on 05/01/20
Period Open: 0.7783
1.2900 -23.26%
on 05/26/20
+0.2117 (+27.20%)
since 04/28/20
3-Month
0.6191 +59.91%
on 03/19/20
Period Open: 1.1400
1.3200 -25.00%
on 03/04/20
-0.1500 (-13.16%)
since 02/28/20
52-Week
0.6191 +59.91%
on 03/19/20
Period Open: 2.6600
2.7600 -64.13%
on 05/29/19
-1.6700 (-62.78%)
since 05/28/19

Business Summary

Zafgen, Inc. is a biopharmaceutical company. The Company develops therapeutics for patients suffering from obesity and obesity-related disorders. Its lead product candidate includes Beloranib, an injection that is in Phase II clinical trials for the treatment of various indications comprising obesity...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 1.3500
1st Resistance Point 1.1700
Last Price 0.9900
1st Support Level 0.8800
2nd Support Level 0.7700
3rd Support Level N/A

See More

52-Week High 2.7600
Fibonacci 61.8% 1.9422
Fibonacci 50% 1.6895
Fibonacci 38.2% 1.4369
Last Price 0.9900
52-Week Low 0.6191

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies